FindTrial
Sign In

A study to show the efficiency of internal radiotherapy of respiratory tract for releasing airway obstruction

Prospective Pilot study of Endobronchial brachytherapy for palliation of malignant airway obstruction

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/03/018346
Enrollment
15
Registered
2019-03-29
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C349- Malignant neoplasm of unspecifiedpart of bronchus or lung Health Condition 2: C349- Malignant neoplasm of unspecifiedpart of bronchus or lung

Interventions

Intervention1: Palliative Endobronchial Brachytherapy: 2 session one week apart each consisting of 7.5Gy. Control Intervention1: NA: NA

Sponsors

All India Institute of medical sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Biopsy Proven Lung Malignancy 2.ECOG PS 0-III 3.Informed consent

Exclusion criteria

Exclusion criteria: ï?? Uncontrolled comorbid condition ï?? Unconfirmed histology ï?? PS-IV ï?? Deranged Renal and liver function tests ï?? Bleeding disorders( Haemophilia, idiopathic Thrombocytopenia)

Design outcomes

Primary

MeasureTime frame
To assess the efficacy of endobronchial brachytherapy as a palliative procedure in releasing airway obstruction and controlling haemoptysisTimepoint: 1 week(clinical response) 1 month(response assesement bronchoscopically )—

Secondary

MeasureTime frame
To assess the toxicity profile and Local control rate of patients treated with Endobronchial brachytherapyTimepoint: 3 monthly upto 2 years—

Countries

India

Contacts

Public ContactRambha Pandey

AII India Institute of Medical Sciences, New Delhi

rambha151@gmail.com01129575228

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026